Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments

医学 药剂师 不利影响 内科学 药店 急诊医学 重症监护医学 家庭医学
作者
Jessie Signorelli,Christopher Bell,Stéphanie Monaco
出处
期刊:Journal of Oncology Pharmacy Practice [SAGE]
卷期号:: 107815522211126-107815522211126 被引量:1
标识
DOI:10.1177/10781552221112603
摘要

Patients on oral oncolytics are responsible for self-monitoring adherence and adverse drug reactions (ADRs). Oncology pharmacists are in position to focus on quality and safety of care for patients on oncolytics while providing communication between the patient, physician, and specialty pharmacies. This pilot aimed to monitor patients treated by our leukemia team initiated on oral oncolytics.From July 2020 to February 2021, patients treated by our leukemia team newly started on oncolytics were included. Pharmacists performed medication reconciliation and drug interaction screening on initiation of oral oncolytic. Pharmacists followed up at predefined intervals. On follow up adherence was assessed using the Morisky Medication Adherence Scale-8 (MMAS-8) and patient reported outcomes (PROs) were assessed using the revised Edmonton Symptom Assessment Scale (ESAS-r). After each follow-up, a note was placed in the chart with assessment scores and recommendations.A total of 32 patients were screened with 19 patients included. Oral oncolytics included: imatinib (4), dasatinib (5), ponatinib (1), gilteritinib (2), enasidenib (1), and venetoclax (6). Fourteen drug interactions were identified, 11 medications discontinued, nine medications added, and two medications doses were changed. Twenty-six adherence assessments were performed with 21, 4, and 1 assessment demonstrating adherence, medium adherence, and low adherence, respectively. 62 ESAS-r assessments were performed with 64% reported as no symptoms, 17% as mild, 13% as moderate, and 5% as severe symptoms. Twenty laboratory tests were ordered from pharmacist recommendation on initiation and follow-up.This pilot demonstrated the role pharmacists play in oral oncolytic monitoring and symptom management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
36456657应助江边鸟采纳,获得20
刚刚
可爱的函函应助Charles采纳,获得10
刚刚
Hello应助感动的冬云采纳,获得10
1秒前
桐桐应助感动的冬云采纳,获得10
1秒前
1秒前
1秒前
FashionBoy应助板栗采纳,获得10
1秒前
香蕉觅云应助碧瑜采纳,获得10
2秒前
俏皮的安萱完成签到 ,获得积分10
2秒前
开朗向真发布了新的文献求助10
4秒前
5秒前
5秒前
6秒前
风趣雅旋完成签到,获得积分10
6秒前
8秒前
科研通AI2S应助顺利毕业采纳,获得10
8秒前
wangbq完成签到 ,获得积分10
8秒前
8秒前
8秒前
iris发布了新的文献求助10
9秒前
赘婿应助科研通管家采纳,获得10
9秒前
ding应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
充电宝应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
英俊的铭应助科研通管家采纳,获得10
10秒前
李健应助科研通管家采纳,获得10
10秒前
李爱国应助科研通管家采纳,获得10
10秒前
领导范儿应助科研通管家采纳,获得10
10秒前
Akim应助科研通管家采纳,获得30
10秒前
彭于晏应助科研通管家采纳,获得10
10秒前
monere应助科研通管家采纳,获得20
10秒前
情怀应助科研通管家采纳,获得10
10秒前
wen发布了新的文献求助10
11秒前
11秒前
李文思发布了新的文献求助10
11秒前
chuan完成签到,获得积分10
11秒前
个性的紫菜应助DONG采纳,获得50
12秒前
科目三应助hger采纳,获得10
12秒前
12秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Fundamentals of Dispersed Multiphase Flows 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3254449
求助须知:如何正确求助?哪些是违规求助? 2896608
关于积分的说明 8293494
捐赠科研通 2565573
什么是DOI,文献DOI怎么找? 1393134
科研通“疑难数据库(出版商)”最低求助积分说明 652418
邀请新用户注册赠送积分活动 629955